Highlighting the Mitochondrial Micro-Proteome as a Platform for Healthspan-Related Drug Discovery

Time: 2:15 pm
day: Day Two


  • Discussing how the mtDNA contains hundreds of previously unrecognized small open-reading frames that encode a novel class of mitochondrial-derived peptides (MDPs)
  • Exploring several new and innovative bioinformatic approaches that allow the discovery of disease relevant MDPs that can serve as targets for diseases of aging
  • Evaluating specific MDPs that are mutated in conditions such as diabetes and Alzheimer’s disease represent novel precision-aging treatment strategies